Study of the Bioequivalence of the 20% and 30% Etoricoxib Tablet Formulations (0663-070)
Status:
Completed
Trial end date:
2002-12-01
Target enrollment:
Participant gender:
Summary
This study will establish the bioequivalence of the 20%, milled, roller compaction final
market image (FMI) etoricoxib tablets and 30% unmilled, roller compaction (UMC) etoricoxib
tablets.